
Anthony J. Calandra
Examiner (ID: 14816, Phone: (571)270-5124 , Office: P/1741 )
| Most Active Art Unit | 1748 |
| Art Unit(s) | 1791, 1748, 1741 |
| Total Applications | 1151 |
| Issued Applications | 661 |
| Pending Applications | 116 |
| Abandoned Applications | 406 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18027760
[patent_doc_number] => 11510920
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-11-29
[patent_title] => Compositions and methods for treating EZH2-mediated cancer
[patent_app_type] => utility
[patent_app_number] => 16/926418
[patent_app_country] => US
[patent_app_date] => 2020-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 57
[patent_no_of_words] => 32678
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16926418
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/926418 | Compositions and methods for treating EZH2-mediated cancer | Jul 9, 2020 | Issued |
Array
(
[id] => 17837616
[patent_doc_number] => 20220274921
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-01
[patent_title] => PHENYL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR THERAPEUTIC APPLICATIONS
[patent_app_type] => utility
[patent_app_number] => 17/625698
[patent_app_country] => US
[patent_app_date] => 2020-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29182
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -80
[patent_words_short_claim] => 683
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17625698
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/625698 | PHENYL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR THERAPEUTIC APPLICATIONS | Jul 9, 2020 | Pending |
Array
(
[id] => 17850431
[patent_doc_number] => 20220280472
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-08
[patent_title] => TREATMENT OF PULMONARY FIBROSIS USING INHIBITORS OF NEU1 SIALIDASE
[patent_app_type] => utility
[patent_app_number] => 17/625059
[patent_app_country] => US
[patent_app_date] => 2020-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26060
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17625059
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/625059 | TREATMENT OF PULMONARY FIBROSIS USING INHIBITORS OF NEU1 SIALIDASE | Jul 7, 2020 | Pending |
Array
(
[id] => 17407136
[patent_doc_number] => 11248005
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-02-15
[patent_title] => Process for preparation of intermediates used for the synthesis of HIV integrase inhibitor
[patent_app_type] => utility
[patent_app_number] => 16/922260
[patent_app_country] => US
[patent_app_date] => 2020-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4251
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16922260
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/922260 | Process for preparation of intermediates used for the synthesis of HIV integrase inhibitor | Jul 6, 2020 | Issued |
Array
(
[id] => 20172969
[patent_doc_number] => 12391701
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-08-19
[patent_title] => Chromene-based compounds, methods and uses thereof
[patent_app_type] => utility
[patent_app_number] => 17/560859
[patent_app_country] => US
[patent_app_date] => 2020-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 11968
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17560859
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/560859 | Chromene-based compounds, methods and uses thereof | Jun 28, 2020 | Issued |
Array
(
[id] => 16374369
[patent_doc_number] => 20200323211
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-15
[patent_title] => BENZOSULTAMS AND ANALOGUES AND THEIR USE AS FUNGICIDES
[patent_app_type] => utility
[patent_app_number] => 16/913862
[patent_app_country] => US
[patent_app_date] => 2020-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 74682
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 155
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16913862
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/913862 | Benzosultams and analogues and their use as fungicides | Jun 25, 2020 | Issued |
Array
(
[id] => 16360916
[patent_doc_number] => 20200317667
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-08
[patent_title] => INHIBITORS OF PLASMA KALLIKREIN AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/908497
[patent_app_country] => US
[patent_app_date] => 2020-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 153467
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 574
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16908497
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/908497 | Inhibitors of plasma kallikrein and uses thereof | Jun 21, 2020 | Issued |
Array
(
[id] => 17913182
[patent_doc_number] => 20220315577
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-06
[patent_title] => NEW EGFR INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 17/620235
[patent_app_country] => US
[patent_app_date] => 2020-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7212
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 169
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17620235
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/620235 | NEW EGFR INHIBITORS | Jun 18, 2020 | Abandoned |
Array
(
[id] => 20142747
[patent_doc_number] => 12377062
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-08-05
[patent_title] => Antimicrobial solutions
[patent_app_type] => utility
[patent_app_number] => 17/619373
[patent_app_country] => US
[patent_app_date] => 2020-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5351
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 234
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17619373
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/619373 | Antimicrobial solutions | Jun 17, 2020 | Issued |
Array
(
[id] => 17790380
[patent_doc_number] => 20220249471
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-11
[patent_title] => NEW THERAPEUTIC APPROACH TO LUNG DISEASE
[patent_app_type] => utility
[patent_app_number] => 17/618700
[patent_app_country] => US
[patent_app_date] => 2020-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9892
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17618700
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/618700 | Therapeutic approach to lung disease | Jun 11, 2020 | Issued |
Array
(
[id] => 19977160
[patent_doc_number] => 12344621
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-07-01
[patent_title] => CGRP antagonist compounds
[patent_app_type] => utility
[patent_app_number] => 17/617873
[patent_app_country] => US
[patent_app_date] => 2020-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24774
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 96
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17617873
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/617873 | CGRP antagonist compounds | Jun 11, 2020 | Issued |
Array
(
[id] => 16932408
[patent_doc_number] => 20210198297
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-01
[patent_title] => ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME AND DIAGNOSTIC COMPOSITION INCLUDING THE ORGANOMETALLIC COMPOUND
[patent_app_type] => utility
[patent_app_number] => 16/895293
[patent_app_country] => US
[patent_app_date] => 2020-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 56460
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 1217
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16895293
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/895293 | Organometallic compound, organic light-emitting device including the same and diagnostic composition including the organometallic compound | Jun 7, 2020 | Issued |
Array
(
[id] => 20185869
[patent_doc_number] => 12396969
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-08-26
[patent_title] => Compounds and methods for the treatment of parasitic infections
[patent_app_type] => utility
[patent_app_number] => 17/616771
[patent_app_country] => US
[patent_app_date] => 2020-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 12
[patent_no_of_words] => 14331
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17616771
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/616771 | Compounds and methods for the treatment of parasitic infections | Jun 4, 2020 | Issued |
Array
(
[id] => 20433219
[patent_doc_number] => 12503438
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-12-23
[patent_title] => Compounds for the treatment of kinase-dependent disorders
[patent_app_type] => utility
[patent_app_number] => 17/616120
[patent_app_country] => US
[patent_app_date] => 2020-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 51872
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 135
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17616120
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/616120 | Compounds for the treatment of kinase-dependent disorders | Jun 2, 2020 | Issued |
Array
(
[id] => 17134786
[patent_doc_number] => 11136332
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-10-05
[patent_title] => Morphic forms of marizomib and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/886301
[patent_app_country] => US
[patent_app_date] => 2020-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 46
[patent_figures_cnt] => 46
[patent_no_of_words] => 22291
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16886301
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/886301 | Morphic forms of marizomib and uses thereof | May 27, 2020 | Issued |
Array
(
[id] => 17776535
[patent_doc_number] => 20220242884
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-04
[patent_title] => DNA-DEPENDENT PROTEIN KINASE INHIBITOR
[patent_app_type] => utility
[patent_app_number] => 17/614384
[patent_app_country] => US
[patent_app_date] => 2020-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26371
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17614384
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/614384 | DNA-DEPENDENT PROTEIN KINASE INHIBITOR | May 25, 2020 | Pending |
Array
(
[id] => 17634998
[patent_doc_number] => 11345711
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-05-31
[patent_title] => 8,9-dihydroimidazo[1,2-a]pyrimido[5,4-e]pyrimidin-5(6H)-ones
[patent_app_type] => utility
[patent_app_number] => 16/883397
[patent_app_country] => US
[patent_app_date] => 2020-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26374
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 407
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16883397
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/883397 | 8,9-dihydroimidazo[1,2-a]pyrimido[5,4-e]pyrimidin-5(6H)-ones | May 25, 2020 | Issued |
Array
(
[id] => 20593560
[patent_doc_number] => 12577262
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-03-17
[patent_title] => Functionalized gold carbene napthaquinone complexes for use in the treatment of cancer
[patent_app_type] => utility
[patent_app_number] => 17/595670
[patent_app_country] => US
[patent_app_date] => 2020-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 29
[patent_no_of_words] => 29807
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 503
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17595670
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/595670 | Functionalized gold carbene napthaquinone complexes for use in the treatment of cancer | May 21, 2020 | Issued |
Array
(
[id] => 17761460
[patent_doc_number] => 20220235072
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-28
[patent_title] => SEMI-SYNTHETIC ANALOGUES OF EPIPOLYTHIODIOXOPIPERAZINE ALKALOIDS
[patent_app_type] => utility
[patent_app_number] => 17/613640
[patent_app_country] => US
[patent_app_date] => 2020-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25576
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17613640
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/613640 | Semi-synthetic analogues of epipolythiodioxopiperazine alkaloids | May 21, 2020 | Issued |
Array
(
[id] => 17702011
[patent_doc_number] => 20220202017
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-30
[patent_title] => MESOIONIC IMIDAZOLIUM COMPOUNDS AND DERIVATIVES FOR COMBATING ANIMAL PESTS
[patent_app_type] => utility
[patent_app_number] => 17/607072
[patent_app_country] => US
[patent_app_date] => 2020-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38468
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17607072
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/607072 | MESOIONIC IMIDAZOLIUM COMPOUNDS AND DERIVATIVES FOR COMBATING ANIMAL PESTS | May 18, 2020 | Pending |